AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
28 Maggio 2024 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the Goldman Sachs 45th Annual Global
Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m.
Pacific Time (3:20 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody
medicines for indications across therapeutic areas including
cancer, metabolic and endocrine conditions, and autoimmune
disorders. AbCellera’s engine integrates technology, data science,
infrastructure, and interdisciplinary teams to solve the most
challenging antibody discovery problems. AbCellera is focused on
advancing an internal pipeline of first-in-class and best-in-class
programs and collaborating on innovative drug development programs
with partners. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240528369330/en/
Inquiries Media: Kathleen Reid; media@abcellera.com,
+1(236)521-6774 Business Development: Murray McCutcheon, Ph.D.;
bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie
Solomon; ir@abcellera.com, +1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Gen 2024 a Gen 2025
